Articles On Genetic Technologies (ASX:GTG)
Title | Source | Codes | Date |
---|---|---|---|
ASX Health Winners April: Mesoblast leads; and why the Health sector is just built different
ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month The S&P/ASX 200 Health Care [XHJ] had a soft month in April... |
Stockhead | GTG | 1 day ago |
Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners
There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month Scientists have made a significant b... |
Stockhead | GTG | 1 week ago |
Top 10 at 10: Here comes this project’s first gold drilling program in over a decade
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GTG | 2 weeks ago |
Genetic Technologies kicks off US breast cancer imaging campaign
Dual ASX and NASDAQ smallcap Genetic Technologies (ASX:GTG) has announced its launch of a breast cancer imaging program across three US clinics in NY, Miami and Houston, Texas. The program will integrate GTG’s “geneType” saliva-based and... |
themarketonline.com.au | GTG | 3 weeks ago |
Market Update: ASX takes a breather from lofty peaks
The ASX200 is down nearly half a per cent – beating futures predictions. Aside from health care and real estate, most sectors have been in the red so far. In this bulletin, we’ll look at news from Fisher & Paykel Healthcare Corpor... |
themarketonline.com.au | GTG | 1 month ago |
Genetic Technologies unveils revolutionary cancer detection test
Genetic Technologies (ASX:GTG), known for its expertise in genomics-based testing, has introduced its most advanced risk assessment test for serious diseases – including breast and ovarian cancer. This new test builds upon the success of it... |
themarketonline.com.au | GTG | 1 month ago |
Genetic Technologies unveils GeneType test for unprecedented disease risk assessment
Molecular diagnostics company Genetic Technologies (ASX: GTG) has announced a major breakthrough in risk assessment tests for serious diseases. The new GeneType technology builds on the success of the company’s comprehensive hereditary brea... |
smallcapsau.mystagingwebsite.com | GTG | 1 month ago |
ASX Health Winners February: Law of attrition applies but biotech is a long term game; Nyrada up 5x last month
ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr... |
Stockhead | GTG | 1 month ago |
Top 10 at 11: Half year results and legal woes are making news today
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | GTG | 2 months ago |
Check Up: Big week in world of biotech after these 2 Nasdaq stocks announce breakthroughs
Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks There were a couple of big news from the world of biotec... |
Stockhead | GTG | 2 months ago |
Top 10 at 10: Special EV loans, M&A, and a big Brazil REE buy
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GTG | 5 months ago |
10 at 11ish: Aurumin to sell iron rights to Mineral Resources
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by... |
Stockhead | GTG | 5 months ago |
Closing Bell: The ASX is slightly higher, but not much cooler on Monday
The ASX benchmark has closed slightly higher on Monday Energy Sector gains after oil prices rose over the weekend Small caps led Killi Resources, Nyrada and Viridis Mining The Aussie sharemarket has ended the opening salvo of the week... |
Stockhead | GTG | 5 months ago |
Closing Bell: ASX ends it like Beckham… lower and with a pretty whimper, which could still suggest good things ahead
The ASX benchmark has closed slightly lower on Friday Losses across the Energy Sector weighed Small caps led ID8 The Aussie sharemarket has ended lower on Friday, driven to a small disgrace by the ongoing declines in oil prices – down... |
Stockhead | GTG | 5 months ago |
Top 10 at 11: Buy-ups, Buy-outs and Payouts are what’s moving the market this morning
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by... |
Stockhead | GTG | 5 months ago |
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners
Xi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks China’s President Xi is expected... |
Stockhead | GTG | 5 months ago |
Closing Bell: Australian stocks go higher, for longer on bets The Fed won’t have to
The ASX has ended Wednesday jumping almost 100 points. Huge effort, everyone Energy Sector misses out on all the positive vibes Small caps led by Findi and Firebrick Pharma The Australian sharemarket is in fine fettle on this Wednesday... |
Stockhead | GTG | 5 months ago |
Closing Bell: Broad-based whinging leads ASX back to the start of 2023, minus the hope and ignorance
The ASX has ended -0.4% lower, just 2.5 points from 2023 parity Utilities only sector in green Small caps led by 4DX, Infinity and a few Lake Johnston lithium plays The local market is back to digging its little hole from which it may t... |
Stockhead | GTG | 5 months ago |
Closing Bell: ASX gains trimmed by deflating Chinese data, however it’s Kristmas at Krakatoa with thick peggies for all
The ASX has closed higher Healthcare leads sector gains Small caps led by KTA and FG1 The Aussie sharemarket has trimmed the fat off this morning’s substantial gains – at one stage there we were easing past the 7,350 mark and off to th... |
Stockhead | GTG | 5 months ago |
10 at 11ish: Thick peggies = 73pc pop. Krakatoa cracks the lithium code at King Tamba
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by... |
Stockhead | GTG | 5 months ago |
Closing Bell: Smart and casual, ASX makes it five in a row; next up – rates and horse races
ASX200 closes +0.28% higher Healthcare leads gains, ASX All Gold rises over +3% Small caps led by takeover target Whispir The Australian sharemarket has ended higher on the first day of what is certain to be another week of intensely tr... |
Stockhead | GTG | 5 months ago |
Closing Bell: Even the Aussie dollar appreciates a good lead as dynamic surge makes local IT the it sector for a day
ASX200 closes 0.9pc higher Property stocks and IT sector enjoy huge day Small caps led by DCL The Australian sharemarket has lifted strongly on Day Two of Trading in November, the Best Month for Trading Ever. Local investors got stuck r... |
Stockhead | GTG | 6 months ago |
Closing Bell: It certainly wasn’t cricket as Monday markets in Australia knocked right back to last year
Benchmark ASX index closes at new 12-month lows Energy and Materials the worst of 9 dipping ASX sectors on Monday Small caps led by CHM, TON On Monday Aussie markets rediscovered their nadir of the year. No real surprises, since every n... |
Stockhead | GTG | 6 months ago |
Top 10 at 11: This morning is all about lithium, graphite and the fight against Glioblastoma
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by... |
Stockhead | GTG | 6 months ago |
Top 10 at 11: Copper, Gold and Lithium are keeping the market’s doors open this morning
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by... |
Stockhead | GTG | 6 months ago |
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff
News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks Goldman Sachs analysts said they will make no... |
Stockhead | GTG | 6 months ago |
Traders’ Diary: A week of War, Worry and Wall Street earnings
The Week That Was The world looks very different this week after the addition of what Barclays economic team calls ‘a complex cocktail of geopolitical risk, mixed macro data, a nervous oil market,’ and a US Fed finding nice things to say ab... |
Stockhead | GTG | 6 months ago |
Closing Bell: Noxopharm ignores screams as unsuspecting local markets ambushed by hellish bank-tech-comms beastie
Benchmark index falls to 11-month lows Utilities only sector in green Small caps led by Noxopharm Local markets have extended unexpected October losses on Wednesday as tech stocks, and the Financial Sector led losses on another bond-... |
Stockhead | GTG | 6 months ago |
Closing Bell: Bleak benchmark goes back to the beginning as Wall Street worries widen; RBA holds at 4.1pc
ASX200 drops sharply on Wall Street worry Healthcare only sector to rise Small caps led by Noxopharm, Nimy Resources, Alderan and ECS Botanics The ASX200 has inched below where it was at the start of 2023, while the Australian dollar... |
Stockhead | GTG | 6 months ago |
Closing Bell: ASX trips at starting gun while US Futures jump on world not ending yet
Benchmark index falls on Monday, closing out the day down 0.21% Utilities and Materials sectors edge higher, but Health Care anchors the benchmark into the red Small caps led by Galileo Mining, Infinity and last week’s rockstar Biotron... |
Stockhead | GTG | 7 months ago |
Hot Money Monday: These are the top momentum stocks; and introducing the Simple Moving Average
We look at which ASX stocks are trading on a momentum 52-week high and RSI are two indicators of momentum Simple Moving Average is also another measure of momentum Last week, we looked at how traders find stocks that are trading with mo... |
Stockhead | GTG | 7 months ago |
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it
L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks Be... |
Stockhead | GTG | 7 months ago |
Closing Bell: Local markets fall on timid Tuesday but Biotron bets build as investors ask if it’s aced an anti-viral AIDS therapy
Benchmark index settles almost -0.6% lower on Tuesday All sectors bar Healthcare and Financials in the red Small caps led by NickelSearch and Biotron A positive lead from Wall Street overnight didn’t sell well on local markets, which were... |
Stockhead | GTG | 7 months ago |
Top 10 at 11: Uranium price surge offers a healthy glow to an otherwise weird market
Stockhead’s Top 10 at shortly-before-11-ish, published through a haze of that horrible “I’m awake and doing stuff but my heart’s still asleep” feeling that I’ve decided to blame on the post-50-years-old blues, and not on the recent launch o... |
Stockhead | GTG | 7 months ago |
Closing Bell: Local markets shed 0.6pc as we brace for tonight’s US Fed call
The ASX 200 benchmark falls 0.6% as we brace for news from The Fed Sector losses led by Resources, while Consumers make gains Small caps led by Alderan, and BNPL Sezzle returns Local markets made it a hat trick of losses, with the re... |
Stockhead | GTG | 7 months ago |
ASX cancer stocks guide: Here’s everything you need to know
According to the World Health Organisation (WHO), cancer is the leading cause of death globally. WHO defines cancer as a generic term for a large group of diseases that can affect any part of the body with malignant tumours and neoplasms. W... |
Stockhead | GTG | 7 months ago |
Closing Bell: A lean green Friday on the screen as ASX climbs 1.3%, rides upbeat economic vibes
ASX 200 closes 1.3% higher, adds 1.5% for the week All Sectors in the green following strong Chinese data drop Small caps led by OZM, uranium stocks Australian shares have risen strongly on Friday following decent overnight leads from... |
Stockhead | GTG | 7 months ago |
Closing Bell: Resources to the ASX rescue, but it’s uranium that’s gone nuclear
ASX 200 closes 0.46% higher after building up slowly all day Uranium goes off. Materials, Finance Sectors call the shots Small caps led by an all uranium cast, including Australian shares have been lifted despite a mixed overnight lea... |
Stockhead | GTG | 7 months ago |
Check Up: What is the FDA emergency use authorisation, and which ASX stocks were given approval?
The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks On... |
Stockhead | GTG | 7 months ago |
Top 10 at 11: This morning’s early gains are brought to you by lithium, nickel and… almonds.
Stockhead’s Top 10 at shortly-before-11-ish, published shortly after I’ve located my reading glasses and wiped the bacon grease off my fingers at the start of each trading day. It highlights the best (and sometimes worst) performing ASX sto... |
Stockhead | GTG | 7 months ago |
ASX Health Stocks: Lumos granted US FDA emergency-use approval for virus test kit, ViraDx
Lumos granted approvals by the US FDA for the ViraDx test Imugene receives positive feedback from FDA for CAR T cell therapy Genetic Technology expands its geneType Multi-Risk Test in Australia Lumos granted US FDA approval for ViraDx M... |
Stockhead | GTG | 7 months ago |
Top 10 at 10: Upgraded sales forecasts and a lucrative M&A deal
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GTG | 7 months ago |
Market Highlights: Shares to open higher, Goldman cuts recession odds, and 5 ASX small caps to watch
The ASX is set to edge higher on Monday US Energy stocks lifted, while mega tech stocks fell Goldman cut US recession probability to just 15% Australian shares are set to edge higher on Monday after US stocks closed slightly up on Frida... |
Stockhead | GTG | 7 months ago |
Closing Bell: Minus Energy, the ASX benchmark and small cap indices had a silly day of depressing trade
ASX 200, Small Ords and Emerging Co’s indices all close -0.8% in the red Only the Energy Sector finds some green Small caps led by teeny-tiny energy minnow CCE The Australian sharemarket dropped on Wednesday, dragged down by miners and... |
Stockhead | GTG | 7 months ago |
ASX Biotech August Winners: Sector down despite CSL and Cochlear’s strong results, but don’t panic…
Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August August was all about earnings, and des... |
Stockhead | GTG | 7 months ago |
Check Up: Australian biotech sector continues to be a magnet for US investors
Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the best and worst performing ASX biotechs over the past month The Australian biotech sector co... |
Stockhead | GTG | 8 months ago |
Top 10 at 10: Red Sky jumps 20pc on news of 100pc offtake deal with Viva
Stockhead’s Top 10 at 11, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GTG | 8 months ago |
Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money will go
Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month Steve Jobs used to say that the most... |
Stockhead | GTG | 8 months ago |
CLOSING BELL: ASX eases to 0.39pc, led to greener pastures by a surging Health Care market
The ASX 200 benchmark has climbed down from highs at lunch to finish on +0.39%. Health Care was well out in front of the market all day, thanks to a chunky bump for CSL. Voltaic Strategic Resources won the Small Caps Cup, rising 22.5% for... |
Stockhead | GTG | 8 months ago |
Top 10 at 10: Stelar Metals and Lake Resources lead the lithium news this morning
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GTG | 8 months ago |